ASSURE WCD Clinical Evaluation - Conversion Efficacy Study

NCT04132466 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Death, Sudden, Cardiac

Interventions

DEVICE: Defibrillation using the ASSURE wearable cardioverter defibrillator therapy delivered via a waveform delivery test system

Sponsor

Kestra Medical Technologies, Inc.

Collaborators

[object Object]